Editorial ArticleLife Sciences
Getting organoids into the clinic
Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice
It is essential to test the efficacy and toxicity of drugs at every stage of their development to ensure that a pharmaceutical product is fit for purpose and safe for use before reaching the stage of mass production and distribution.
Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice